首页 | 本学科首页   官方微博 | 高级检索  
检索        

生脉注射液与冠心病胰岛素抵抗的临床研究
引用本文:杨昱,银翠云,杨溢,赵蜀琼.生脉注射液与冠心病胰岛素抵抗的临床研究[J].武警医学院学报,2004,13(5):363-365.
作者姓名:杨昱  银翠云  杨溢  赵蜀琼
作者单位:武警广东总队医院内四科,广东,广州,510507
摘    要:【目的】观察生脉注射液对冠心病患者胰岛素抵抗的影响。【方法】将 72例冠心病患者分为生脉治疗组和常规治疗组。生脉治疗组在常规治疗的基础上静脉滴注生脉注射液 4w ,治疗前后测血糖、胰岛素和血脂。【结果】生脉治疗组治疗前后胰岛素敏感指数有显著性差异 (P <0 0 1 )。【结论】生脉注射液可改善胰岛素抵抗 ,对防止有胰岛素抵抗因素在内的疾病有很大的临床意义。

关 键 词:生脉注射液  冠心病  胰岛素抵抗  血脂
文章编号:1008-5041(2004)05-0363-03
修稿时间:2004年3月17日

Clinical study of effect of shengmai injection on insulin resistance in patients with coronary heart disease
YANG Yu,YIN Cui yun,YANG Yi,ZHAO Shu qiong.Clinical study of effect of shengmai injection on insulin resistance in patients with coronary heart disease[J].Acta Academiae Medicinae CPAPF,2004,13(5):363-365.
Authors:YANG Yu  YIN Cui yun  YANG Yi  ZHAO Shu qiong
Abstract:To observe the effect of sheng mai injection(SMI) on insulin resistance in patients with coronary heart disease(CHD).72 CHD cases were randomly divided into the SMI on the basis of routine treatment.The changes of blood glucose,plasma insulin and blood lipid were measured before and after treatment.After SMI treatment,insulin sensitivity index lowered( P <0 01).There was significant difference compared with control group after treatment( P <0 01).Conclusion]SMI can improve the insulin resistance in the patients with CHD and bears great clinical significance for the prevention and treatment of the diseases involved with insulin resistance.
Keywords:Shengmai injection  Coronary heart disease  Insulin resistance  Blood lipid
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号